Gene: FAM167A
Official Full Name: family with sequence similarity 167 member Aprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25415 | FAM167A Knockout cell line (HCT 116) | Human | FAM167A | 1:2~1:4 | Negative | Online Inquiry |
KO25416 | FAM167A Knockout cell line (HEK293) | Human | FAM167A | 1:3~1:6 | Negative | Online Inquiry |
KO25417 | FAM167A Knockout cell line (A549) | Human | FAM167A | 1:3~1:4 | Negative | Online Inquiry |
FAM167A Gene Knockout Cell Lines represent a pioneering step in the field of gene editing technology, specifically designed to facilitate in-depth investigations of the FAM167A gene's role in various biological processes. These cell lines are genetically modified versions of human or animal cells in which the FAM167A gene has been completely disabled or "knocked out." This gene is associated with crucial immune response functions, making it an important target for research in immunology and cell biology.
The primary function of FAM167A gene knockout cell lines is to enable researchers to study the physiological and pathological consequences of FAM167A loss. By employing techniques such as CRISPR/Cas9 gene editing, these knockout lines allow for the precise examination of gene function and its interplay within signaling pathways. The absence of FAM167A enables the investigation of downstream effects on cellular mechanisms like cytokine signaling, immune cell differentiation, and overall cellular responses to stimuli.
These cell lines are invaluable in both research and clinical settings. In research, they provide a robust model for understanding autoimmune disorders, cancer immunology, and therapeutic responses. Clinically, insights gained from using these cell lines can pave the way for the development of targeted therapies that modulate immune responses or enhance cancer treatment efficacy.
What sets FAM167A Gene Knockout Cell Lines apart from conventional cell lines is their specificity and ability to model diseases related to the immune system with unparalleled accuracy. Traditional models may lack the precise phenotypic changes observed in FAM167A knockout, which can diminish the reliability of research findings. Moreover, the user-friendly nature of these knockout cell lines allows for straightforward integration into existing experimental protocols.
For researchers and clinicians seeking to advance their understanding of immune regulation or to explore novel therapeutic avenues, FAM167A Gene Knockout Cell Lines offer an innovative, reliable tool. They are essential for elucidating gene function and translating discoveries into real-world medical advancements. Leveraging our years of expertise in genetic engineering and cell line development, we are committed to providing high-quality biological research products that empower the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.